 Home > Biochemistry News > Biotechnology News > New ways to develop new ways to activate T-cell anti-cancer response received $80 million in assistance

New ways to develop new ways to activate T-cell anti-cancer response received $80 million in assistance

 Last Update: 2021-12-03
 Source: Internet
 Author: User

Tags

solid lead

shepherd color company

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, ATP Company announced the establishment of Marengo Therapeutics to develop new antibodies targeting T cell receptor (TCR) Vβ variants to achieve the effect of selectively activating anti-tumor T cells, and plans to promote the company’s lead drug candidates in 2022 To the clinic

Although in the field of immuno-oncology, therapies based on activated T cells have made significant progress, less than one-third of patients receiving current treatment methods have a durable response

The company's research and development team found that bacterial superantigens in nature can activate specific T cells by binding to the TCRVβ chain

The company's lead drug candidate STAR0602 is an antibody fusion molecule

Note: The original text has been deleted

Reference materials:

[1] Marengo Therapeutics Launches with $80M from ATP, Appoints CEO Zhen Su, MD, to Deliver Breakthrough Cancer Treatments Using Its Selective T Cell Activation Repertoire (STAR) Platform.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.